Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

kaleo Inc.

www.kaleopharma.com

Latest From kaleo Inc.

Ohio Study Shows Access To Naloxone Soars Without Rx Requirement

JAMA study finds that removing Rx requirement for naloxone in Ohio resulted in a 2,328% increase in orders of the drug dispensed since 2015. Michael Hufford, CEO of a company working on an OTC switch for a naloxone nasal spray, says the results show urgent need for a low-cost OTC product.
OTC Drugs Drug Approval Standards

US FDA's Words Matter: Sharpless Says Injectable Naloxone OK For Community Distribution

The acting commissioner's statement is intended to clarify "persistent misunderstanding" about the label for the opioid overdose rescue medication's injectable formulation.

Neurology FDA

FDA Prioritizes Reviews Of Opioid Overdose ANDAs

Opioid overdose treatments containing naloxone or nalmefene are now eligible for expedited ANDA review in a bid by the FDA to improve patient access.

Regulation Generic Drugs

US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market

In announcing expedited assessments for new naloxone ANDAs, the agency also offers guidance to sponsors of discontinued products considering a return to marketing.

Generic Drugs Neurology
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Intelliject Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • kaleo Inc.
  • Senior Management
  • T. Spencer Williamson, IV, Pres. & CEO
    Christopher T Schools, CFO
    Kristopher D Ford, VP, Bus. Dev.
    Eric Edwards, MD, PhD, VP, R&D & CMO
  • Contact Info
  • kaleo Inc.
    Phone: (804) 545-6360
    111 Virginia St.
    Ste. 405
    Richmond, VA 23219
    USA
UsernamePublicRestriction

Register